科室及职务
诊疗专长
| 姓名 | 郑勇斌 |
| 出生年月 | 1970年10月 |
| 单位 | 武汉大学人民医院胃肠外科 |
| 所属学科 | 临床医学-普外科 |
| 职务、职称及头衔 | 武汉大学人民医院消化医院副院长，胃肠外科主任，胃肠外I科主任、党支部书记，东院胃肠外科主任，主任医师,博士生导师 |
| yongbinzheng@whu.edu.cn | |
| 联系方式 | 027-88041911转82211 |
| 研究方向 |
1.胃肠道肿瘤的基础与临床研究 2.结直肠癌的局部免疫研究 3.基于神经层面指引的腹腔镜直肠癌根治术研究 |
| 个人简介 | |
| 郑勇斌教授，长期在武汉大学人民医院胃肠外科从事医疗、教学、科研及相关管理工作，荣获“2022魅力医生”荣誉称号。擅长胃肠道肿瘤在内的胃肠外科各种常见病及疑难病治疗，在国际上首先提出“胃肠发育解剖手术”和“基于神经层面指引的直肠癌根治术”，助力推动胃肠道手术的标准化与同质化。主持国家或省部级项目6项，主编身份发表《功能性全直肠系膜切除的直肠肿瘤手术学》专著，以第一作者或通讯作者在知名期刊如Advanced science等杂志累计发表论文100余篇，累积影响因子超100分，至今已完成培养高素质研究生近20余人，博士生2人，在持科研经费超100万。 | |
| 学术任职与荣誉 | |
|
中国NOSES（Natural Orifice Specimen Extraction
Surgery）联盟湖北分会副理事长； 湖北省微循环学会功能性胃肠外科专业委员会主任委员； 武汉医学会临床营养学分会（第一届）常务委员； 湖北省医学会结直肠肛门外科学分会委员会（第三届）副主任委员； 湖北省医学会腹腔镜外科分会委员会（第四届） 副主任委员； 湖北省抗癌协会大肠癌专业委员会（第二届）副主任委员； 湖北省肿瘤医学质量控制中心胃癌与结直肠癌质控专家委员会（第一届）副主任委员； 武汉中西医结合学会外科专业委员会（第四届）副主任委员； 武汉中西医结合学会胃肠外科专业委员会（第一届）副主任委员； 武汉医院协会临床营养管理专业委员会（第一届）副主任委员； 中国医师协会结直肠肿瘤专业委员会第一届委员会并发症管理专业委员会委员； 湖北省医学会肠外肠内营养分会委员会（第二届）ERAS学组组长； 《中华实验外科杂志》编辑委员会（第八届）编委； 《腹部外科杂志》编辑委员会（第五届）编委； 《微循环学杂志》编辑委员会（第六届）委员； 《临床外科杂志》编辑委员会（第四届）编委 |
|
| 教育履历 | |
|
1989.09-1994.07 武汉大学医学院医学学士 1998.09-2001.07 华中科技大学同济医学院医学硕士 2002.09-2005.07 华中科技大学同济医学院医学博士 |
|
| 工作履历 | |
|
1994.07-1998.09 中国人民解放军457医院普通外科 2001.07-2002.09 华中科技大学同济医学院附属协和医院急救中心 2005.07-2011.08. 武汉大学人民医院胃肠外科 2011.08-2012.08 Department of Molecular and Biomedical Pharmacology, Markey Cancer Center, university of Kentucky访问学者 2012.08 -至今 武汉大学人民医院胃肠外科 |
|
| 成果获奖 | |
|
1、广州结直肠癌高峰论坛手术视频大赛优艺奖 2、第九届中国医师协会外科医师年会中青年手术录像比赛三等奖 3、第四届大肠癌高峰论坛视频展播第一名 4、第十五届世界内镜外科大会腹腔镜胃肠外科优秀临床病例选拔大赛最具风采奖 5、中国结直肠外科医师委员会菁英风云榜结直肠手术视频大赛优艺奖 6、大中华结直肠腹腔外科达人训练营获优秀作品奖 7、"2022寻访魅力医生大型公益活动"中荣获"2022魅力医生"荣誉称号 8、第一届“中南医匠”结直肠手术视频比赛三等奖 |
|
| 代表性论著 | |
|
[1] Li S, Wang X, Yan Z, Wang T, Chen Z, Song H,
Zheng Y. Microneedle Patches with Antimicrobial and Immunomodulating
Properties for Infected Wound Healing. Adv Sci (Weinh). 2023 May
18:e2300576. [2] Zeng J, Li K, Cao F, Zheng Y. The development of a prediction model based on deep learning for prognosis prediction of gastrointestinal stromal tumor: a SEER-based study. Sci Rep. 2024;14(1):6609. [3] Zeng J, Song D, Li K, Cao F, Zheng Y. Deep learning model for predicting postoperative survival of patients with gastric cancer. Front Oncol. 2024;14:1329983. [4] Zeng J, Li K, Cao F, Zheng Y. Development and validation of survival prediction model for gastric adenocarcinoma patients using deep learning: A SEER-based study. Front Oncol. 2023 Mar 7;13:1131859. [5] Li K, Zeng J, Pang P, Cheng H, He X, Cao F, Luo Q, Tong S, Zheng Y. Significance of Nerve Plane for Inferior Mesenteric Plexus Preservation in Laparoscopic Rectal Cancer Surgery. Front Oncol. 2022 Apr 22;12:853662. [6] Yang C, Cao F, Huang S, Zheng Y. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer. Front Immunol. 2021 Jul 16;12:717505. [7] Huang X, Zhang J, Zheng Y. ANTXR1 Is a Prognostic Biomarker and Correlates With Stromal and Immune Cell Infiltration in Gastric Cancer. Front Mol Biosci. 2020 Dec 15;7:598221. [8] Cao FY, Wang CH, Li X, Ma MZ, Tao GC, Yang C, Li K, He XB, Tong SL, Zhao QC, Su S, Song D, Zheng YB. Guanylate binding protein 5 accelerates gastric cancer progression via the JAK1-STAT1/GBP5/CXCL8 positive feedback loop. Am J Cancer Res. 2023 Apr 15;13(4):1310-1328. [9] Li J, Yang C, Zheng Y. Identification of a tissue resident memory CD8 T cell-related risk score signature for colorectal cancer, the association with TME landscapes and therapeutic responses. Front Genet. 2023 Jan 4;13:1088230. [10] Li K, Pang P, Cheng H, Zeng J, He X, Cao F, Luo Q, Tong S, Zheng Y. Protective effect of laparoscopic functional total mesorectal excision on urinary and sexual functions in male patients with mid-low rectal cancer. Asian J Surg. 2023 Jan;46(1):236-243. [11] Li X, Song D, Su S, He X, Cao F, Yang C, Li K, Huang S, Li C, Wang C, Zhang A, Pang P, Zheng Y. Critical role of guanylate binding protein 5 in tumor immune microenvironment and predictive value of immunotherapy response. Front Genet. 2022 Sep 30;13:984615. [12] Li K, He X, Tong S, Zheng Y. Risk factors for sexual dysfunction after rectal cancer surgery in 948 consecutive patients: A prospective cohort study. Eur J Surg Oncol. 2021 Aug;47(8):2087-2092. [13] Xiao Z, Zheng YB, Dao WX, Luo JF, Deng WH, Yan RC, Liu JS. MicroRNA-328-3p facilitates the progression of gastric cancer via KEAP1/NRF2 axis. Free Radic Res. 2021 Jun;55(6):720-730. [14] Li K, He X, Zheng Y. An Optimal Surgical Plane for Laparoscopic Functional Total Mesorectal Excision in Rectal Cancer. J Gastrointest Surg. 2021 Oct;25(10):2726-2727. [15] Yang C, Huang S, Cao F, Zheng Y. A lipid metabolism-related genes prognosis biomarker associated with the tumor immune microenvironment in colorectal carcinoma. BMC Cancer. 2021 Nov 5;21(1):1182. [16] Li H, Yang C, Cheng H, Huang S, Zheng Y. CAR-T cells for Colorectal Cancer: Target-selection and strategies for improved activity and safety. J Cancer. 2021 Jan 21;12(6):1804-1814. [17] Yang C, Huang S, Cao F, Zheng Y. Role of ferroptosis-related genes in prognostic prediction and tumor immune microenvironment in colorectal carcinoma. PeerJ. 2021 Jul 14;9:e11745. [18] Yang C, Yang Y, Huang X, Li H, Cheng H, Tong S, Zheng Y. A Nomogram Based on Clinicopathologic Features and Preoperative Hematology Parameters to Predict Occult Peritoneal Metastasis of Gastric Cancer: A Single-Center Retrospective Study. Dis Markers. 2020 Dec 9;2020:1418978. [19] Li K, He X, Tong S, Zheng Y. Nerve plane: An optimal surgical plane for laparoscopic rectal cancer surgery? Med Hypotheses. 2021 Sep;154:110657. [20] Huang X, Yang Y, Yang C, Li H, Cheng H, Zheng Y. Overexpression of LBX2 associated with tumor progression and poor prognosis in colorectal cancer. Oncol Lett. 2020 Jun;19(6):3751-3760. |
| Name | YONG BIN ZHENG |
| Date of birth | October，1970 |
| Department | Gastrointestinal Surgery Department，Renmin Hospital,Wuhan University. |
| Title | Vice president of Gastroenterology，Director , Professor，Chief Physician，Ph.D.Supervisor |
| yongbinzheng@whu.edu.cn | |
| TEL | 027-88041911-82211 |
| Research Direction | |
|
1. The basic and clinical study of
gastrointestinal tumors 2.The research of local immunity of colorectal cancer 3.The research of nerve plane-oriented laparoscopic total mesorectal excision(NPO+LTME) |
|
| Personal Profile | |
| Professor Zheng is mainly engaged in basic research and clinical treatment of gastrointestinal tumors, with rich clinical experience and excellent surgical skills. He is proficient in minimally invasive and standardized treatment of gastrointestinal tumors as well as conventional and laparoscopic radical resection of colorectal cancer. The operation process and team of 2D and 3D laparoscopic radical resection for gastrointestinal tumors with inpidual characteristics have been formed. In recent years, He applied Ta-TME operation and ISR+Ta-TME in anus preserving operation for low and ultra-low rectal cancer and gained a lot of experience and achievements in the study of ultra low rectal cancer surgery and pelvicautonomic nerve preservation. He proposed the nerve plane-oriented radical rectal cancer resection for the first time at home and abroad. He has been awarded 1 items for the National Natural Science Foundation , 1 items for Wu JiePing Medical Foundation, 1 items for Chen XiaoPing Foundation for the Development of Science and Technology. He also took charge and participated in the research of Hubei Natural Science Foundation and Hubei science and technology tackling key project. Besides, he published more than 100 academic papers which including 20 SCI. | |
| Selected Publications | |
|
[1] Li S, Wang X, Yan Z, Wang T, Chen Z, Song
H, Zheng Y. Microneedle Patches with Antimicrobial and Immunomodulating
Properties for Infected Wound Healing. Adv Sci (Weinh). 2023 May
18:e2300576. [2] Zeng J, Li K, Cao F, Zheng Y. The development of a prediction model based on deep learning for prognosis prediction of gastrointestinal stromal tumor: a SEER-based study. Sci Rep. 2024;14(1):6609. [3] Zeng J, Song D, Li K, Cao F, Zheng Y. Deep learning model for predicting postoperative survival of patients with gastric cancer. Front Oncol. 2024;14:1329983. [4] Zeng J, Li K, Cao F, Zheng Y. Development and validation of survival prediction model for gastric adenocarcinoma patients using deep learning: A SEER-based study. Front Oncol. 2023 Mar 7;13:1131859. [5] Li K, Zeng J, Pang P, Cheng H, He X, Cao F, Luo Q, Tong S, Zheng Y. Significance of Nerve Plane for Inferior Mesenteric Plexus Preservation in Laparoscopic Rectal Cancer Surgery. Front Oncol. 2022 Apr 22;12:853662. [6] Yang C, Cao F, Huang S, Zheng Y. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer. Front Immunol. 2021 Jul 16;12:717505. [7] Huang X, Zhang J, Zheng Y. ANTXR1 Is a Prognostic Biomarker and Correlates With Stromal and Immune Cell Infiltration in Gastric Cancer. Front Mol Biosci. 2020 Dec 15;7:598221. [8] Cao FY, Wang CH, Li X, Ma MZ, Tao GC, Yang C, Li K, He XB, Tong SL, Zhao QC, Su S, Song D, Zheng YB. Guanylate binding protein 5 accelerates gastric cancer progression via the JAK1-STAT1/GBP5/CXCL8 positive feedback loop. Am J Cancer Res. 2023 Apr 15;13(4):1310-1328. [9] Li J, Yang C, Zheng Y. Identification of a tissue resident memory CD8 T cell-related risk score signature for colorectal cancer, the association with TME landscapes and therapeutic responses. Front Genet. 2023 Jan 4;13:1088230. [10] Li K, Pang P, Cheng H, Zeng J, He X, Cao F, Luo Q, Tong S, Zheng Y. Protective effect of laparoscopic functional total mesorectal excision on urinary and sexual functions in male patients with mid-low rectal cancer. Asian J Surg. 2023 Jan;46(1):236-243. [11] Li X, Song D, Su S, He X, Cao F, Yang C, Li K, Huang S, Li C, Wang C, Zhang A, Pang P, Zheng Y. Critical role of guanylate binding protein 5 in tumor immune microenvironment and predictive value of immunotherapy response. Front Genet. 2022 Sep 30;13:984615. [12] Li K, He X, Tong S, Zheng Y. Risk factors for sexual dysfunction after rectal cancer surgery in 948 consecutive patients: A prospective cohort study. Eur J Surg Oncol. 2021 Aug;47(8):2087-2092. [13] Xiao Z, Zheng YB, Dao WX, Luo JF, Deng WH, Yan RC, Liu JS. MicroRNA-328-3p facilitates the progression of gastric cancer via KEAP1/NRF2 axis. Free Radic Res. 2021 Jun;55(6):720-730. [14] Li K, He X, Zheng Y. An Optimal Surgical Plane for Laparoscopic Functional Total Mesorectal Excision in Rectal Cancer. J Gastrointest Surg. 2021 Oct;25(10):2726-2727. [15] Yang C, Huang S, Cao F, Zheng Y. A lipid metabolism-related genes prognosis biomarker associated with the tumor immune microenvironment in colorectal carcinoma. BMC Cancer. 2021 Nov 5;21(1):1182. [16] Li H, Yang C, Cheng H, Huang S, Zheng Y. CAR-T cells for Colorectal Cancer: Target-selection and strategies for improved activity and safety. J Cancer. 2021 Jan 21;12(6):1804-1814. [17] Yang C, Huang S, Cao F, Zheng Y. Role of ferroptosis-related genes in prognostic prediction and tumor immune microenvironment in colorectal carcinoma. PeerJ. 2021 Jul 14;9:e11745. [18] Yang C, Yang Y, Huang X, Li H, Cheng H, Tong S, Zheng Y. A Nomogram Based on Clinicopathologic Features and Preoperative Hematology Parameters to Predict Occult Peritoneal Metastasis of Gastric Cancer: A Single-Center Retrospective Study. Dis Markers. 2020 Dec 9;2020:1418978. [19] Li K, He X, Tong S, Zheng Y. Nerve plane: An optimal surgical plane for laparoscopic rectal cancer surgery? Med Hypotheses. 2021 Sep;154:110657. [20] Huang X, Yang Y, Yang C, Li H, Cheng H, Zheng Y. Overexpression of LBX2 associated with tumor progression and poor prognosis in colorectal cancer. Oncol Lett. 2020 Jun;19(6):3751-3760. |
学术任职与荣誉
科研成果
| 出诊医生 | 星期一 | 星期二 | 星期三 | 星期四 | 星期五 | 星期六 | 星期日 | |||||||
| 上午 | 下午 | 上午 | 下午 | 上午 | 下午 | 上午 | 下午 | 上午 | 下午 | 上午 | 下午 | 上午 | 下午 | |
| 郑勇斌 | ||||||||||||||
预约方式
武汉大学人民医院
湖北省人民医院